Advanced search
Publication Cover
Cancer Biology & Therapy Volume 14, 2013 - Issue 11
Submit an article Journal homepage
1,531
Views
54
CrossRef citations to date
0
Altmetric
Research Paper

Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo

Xi Yang Department of Radiotherapy; the First Affiliated Hospital of Nanjing Medical University; Nanjing, PR China
,
Baixia Yang Nantong Tumor Hospital; Nantong, PR China
,
Jing Cai Nantong Tumor Hospital; Nantong, PR China
,
Chi Zhang Department of Radiotherapy; the First Affiliated Hospital of Nanjing Medical University; Nanjing, PR China
,
Qu Zhang Department of Radiotherapy; Second People’s Hospital of Lian Yungang; Lian Yungang, PR China
,
Liping Xu Department of Radiotherapy; the First Affiliated Hospital of Nanjing Medical University; Nanjing, PR China
,
Qin Qin Department of Radiotherapy; the First Affiliated Hospital of Nanjing Medical University; Nanjing, PR China
,
Hongcheng Zhu Department of Radiotherapy; the First Affiliated Hospital of Nanjing Medical University; Nanjing, PR China
,
Jianxin Ma Department of Radiotherapy; Second People’s Hospital of Lian Yungang; Lian Yungang, PR China
,
Guangzhou Tao Department of Radiotherapy; Huai’an First People’s Hospital; Huai’an, PR China
,
Hongyan Cheng Department of Synthetic Internal Medicine; the First Affiliated Hospital of Nanjing Medical University; Nanjing, PR China
&
Xinchen Sun Department of Radiotherapy; the First Affiliated Hospital of Nanjing Medical University; Nanjing, PR ChinaCorrespondence[email protected]
 show all
Pages 1068-1073 | Received 06 Jun 2013, Accepted 09 Sep 2013, Published online: 12 Sep 2013

References

  • Shridhar R, Almhanna K, Meredith KL, Biagioli MC, Chuong MD, Cruz A, Hoffe SE. Radiation therapy and esophageal cancer. Cancer Control 2013; 20:97 - 110; PMID: 23571700
  • Bayer C, Vaupel P. Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences. Strahlenther Onkol 2012; 188:616 - 27; http://dx.doi.org/10.1007/s00066-012-0085-4; PMID: 22454045
  • Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM, Slack FJ. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther 2011; 12:908 - 14; http://dx.doi.org/10.4161/cbt.12.10.17681; PMID: 22027557
  • Moeller BJ, Dewhirst MW. HIF-1 and tumour radiosensitivity. Br J Cancer 2006; 95:1 - 5; http://dx.doi.org/10.1038/sj.bjc.6603201; PMID: 16735998
  • Liao D, Johnson RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007; 26:281 - 90; http://dx.doi.org/10.1007/s10555-007-9066-y; PMID: 17603752
  • Sohda M, Ishikawa H, Masuda N, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Sakurai H, et al. Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. Int J Cancer 2004; 110:838 - 44; http://dx.doi.org/10.1002/ijc.20215; PMID: 15170665
  • Moon SY, Chang HW, Roh JL, Kim GC, Choi SH, Lee SW, Cho KJ, Nam SY, Kim SY. Using YC-1 to overcome the radioresistance of hypoxic cancer cells. Oral Oncol 2009; 45:915 - 9; http://dx.doi.org/10.1016/j.oraloncology.2009.04.005; PMID: 19457706
  • Staab A, Fleischer M, Loeffler J, Said HM, Katzer A, Plathow C, Einsele H, Flentje M, Vordermark D. Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro. Strahlenther Onkol 2011; 187:252 - 9; http://dx.doi.org/10.1007/s00066-011-2167-0; PMID: 21437769
  • Singh IP, Mahajan S. Berberine and its derivatives: a patent review (2009 - 2012). Expert Opin Ther Pat 2013; 23:215 - 31; http://dx.doi.org/10.1517/13543776.2013.746314; PMID: 23231038
  • Tillhon M, Guamán Ortiz LM, Lombardi P, Scovassi AI. Berberine: new perspectives for old remedies. Biochem Pharmacol 2012; 84:1260 - 7; http://dx.doi.org/10.1016/j.bcp.2012.07.018; PMID: 22842630
  • Hur JM, Hyun MS, Lim SY, Lee WY, Kim D. The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J Cell Biochem 2009; 107:955 - 64; http://dx.doi.org/10.1002/jcb.22198; PMID: 19492307
  • Liu Q, Jiang H, Liu Z, Wang Y, Zhao M, Hao C, Feng S, Guo H, Xu B, Yang Q, et al. Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS One 2011; 6:e23427; http://dx.doi.org/10.1371/journal.pone.0023427; PMID: 21858113
  • Peng PL, Kuo WH, Tseng HC, Chou FP. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 2008; 70:529 - 42; http://dx.doi.org/10.1016/j.ijrobp.2007.08.034; PMID: 18207031
  • Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG. Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol 2004; 66:612 - 9; PMID: 15322253
  • Hamsa TP, Kuttan G. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators. Drug Chem Toxicol 2012; 35:57 - 70; http://dx.doi.org/10.3109/01480545.2011.589437; PMID: 22145808
  • Zhang Q, Qian Z, Pan L, Li H, Zhu H. Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia. Acta Physiol Hung 2012; 99:311 - 23; http://dx.doi.org/10.1556/APhysiol.99.2012.3.8; PMID: 22982719
  • Yoshimura M, Itasaka S, Harada H, Hiraoka M. Microenvironment and radiation therapy, Biomed Res Int (2013).
  • Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33:207 - 14; http://dx.doi.org/10.1016/j.tips.2012.01.005; PMID: 22398146
  • Harada H, Inoue M, Itasaka S, Hirota K, Morinibu A, Shinomiya K, Zeng L, Ou G, Zhu Y, Yoshimura M, et al. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nat Commun 2012; 3:783; http://dx.doi.org/10.1038/ncomms1786; PMID: 22510688
  • Meijer TW, Kaanders JH, Span PN, Bussink J. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res 2012; 18:5585 - 94; http://dx.doi.org/10.1158/1078-0432.CCR-12-0858; PMID: 23071360

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.